Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Udenyca (pegfilgrastim-cbqv) dosage, administration, and important considerations for cancer patients in India. Understand how this medication helps prevent infections during chemotherapy.
Cancer treatment, particularly chemotherapy, can be a challenging journey. While chemotherapy is highly effective in fighting cancer cells, it can also affect healthy cells in the body, including white blood cells. Low white blood cell counts, a condition known as neutropenia, can significantly increase the risk of serious infections. Udenyca, with its active ingredient pegfilgrastim-cbqv, is a crucial medication prescribed to help prevent neutropenia in adults and children undergoing chemotherapy. This article provides comprehensive information about Udenyca's dosage, how it's administered, and other vital details relevant to patients in India.
Udenyca belongs to a class of drugs called granulocyte colony-stimulating factors (G-CSFs). These are biologic medications, meaning they are derived from living organisms. Udenyca works by stimulating the bone marrow to produce more white blood cells, specifically neutrophils. By increasing the number of these infection-fighting cells, Udenyca helps reduce the risk and duration of neutropenia, thereby lowering the chances of developing febrile neutropenia (neutropenia with fever) and other serious infections during cancer treatment.
Udenyca is typically administered as a single injection for each round of chemotherapy. The standard dosage for adults is 6 mg, delivered in a prefilled syringe containing 0.6 mL of the drug solution. This dosage is usually maintained throughout the treatment course, with the doctor aiming for the smallest effective dose and frequency.
The timing of the Udenyca injection is critical and is usually scheduled:
Your doctor will determine the exact timing based on your specific chemotherapy regimen and overall treatment plan.
For children, the dosage of Udenyca is determined based on their body weight. This ensures that children receive an appropriate and safe amount of the medication.
It's important for parents and caregivers to follow the doctor's instructions precisely regarding pediatric dosages.
Udenyca is given as a subcutaneous injection, meaning it's injected just under the skin. The injection can be administered in several areas of the body:
Initially, a healthcare professional will administer the injection. They may then train you or a caregiver on how to self-administer Udenyca at home if it's deemed appropriate. This provides greater flexibility and convenience for patients undergoing long-term treatment.
If you are trained to administer Udenyca at home, follow these steps carefully:
If you miss a Udenyca dose, it's crucial to consult your doctor or pharmacist immediately. They will provide specific guidance on how to proceed. Remember that Udenyca should only be administered within the specified window relative to your chemotherapy treatment (at least 14 days before or 24 hours after).
While Udenyca is a globally recognized medication, access and specific protocols might have nuances within the Indian healthcare system. Patients should:
You should consult your doctor immediately if you experience any of the following:
The active ingredient in Udenyca is pegfilgrastim-cbqv.
No, Udenyca is not a chemotherapy drug. It is a supportive medication used to help manage a side effect of chemotherapy (low white blood cell count).
Udenyca is administered via injection and is not taken orally, so the concept of taking it with food does not apply.
Udenyca works by stimulating the bone marrow to produce white blood cells. The effects on white blood cell counts are typically seen within a few days of administration.
Udenyca (pegfilgrastim-cbqv) is a biosimilar to Neulasta (pegfilgrastim). Biosimilars are highly similar to an already approved biologic medicine and have no clinically meaningful differences in terms of safety and effectiveness. Your doctor will determine which is appropriate for you.
Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026